Index
RUT
Market Cap
4.77B
Enterprise Value
5.84B
Income
209.58M
Sales
5.69B
Book/sh
8.41
Cash/sh
1.29
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
0.00%
Employees
6528
IPO
Aug 15, 1996
P/E
24.08
Forward P/E
15.28
PEG
1.45
P/S
0.84
P/B
3.78
P/C
24.61
P/FCF
15.69
EV/EBITDA
14.42
EV/Sales
1.03
Quick Ratio
0.98
Current Ratio
1.47
Debt/Eq
1.01
LT Debt/Eq
0.98
Option/Short
Yes / Yes
EPS (ttm)
1.32
EPS next Y
2.08
EPS next Q
0.49
EPS this Y
9.38%
EPS next Y
10.71%
EPS next 5Y
10.52%
EPS past 3/5Y
15.40% -
Sales past 3/5Y
12.72% 13.25%
EPS Y/Y TTM
5.33%
Sales Y/Y TTM
5.95%
EPS Q/Q
14.13%
Sales Q/Q
1.86%
Insider Own
1.76%
Insider Trans
3.51%
Inst Own
107.00%
Inst Trans
-34.30%
ROA
6.20%
ROE
16.00%
ROIC
8.39%
Gross Margin
17.87%
Oper. Margin
5.86%
Profit Margin
3.68%
SMA20
3.16%
SMA50
20.07%
SMA200
20.92%
Trades
Shs Outstand
149.78M
Shs Float
147.17M
52W High
36.80 -13.51%
52W Low
18.01 76.74%
Volatility
0.42% 0.66%
ATR (14)
0.41
RSI (14)
84.25
Beta
0.53
Rel Volume
1.08
Avg Volume
3.92M
Volume
4,228,346
Perf Week
1.95%
Perf Month
40.97%
Perf Quarter
34.30%
Perf Half Y
58.91%
Perf YTD
-0.09%
Perf Year
21.47%
Perf 3Y
18.64%
Perf 5Y
16.47%
Perf 10Y
188.32%
Prev Close
31.85
Price
31.83
Change %
-0.06%
Analysts 10 incl. previous ratings
Rating Distribution 5 Buy · 5 Hold · 0 Sell
Date Action Analyst Rating Change Price Target Change Implied Upside Jul 30, 2026 Downgrade D Deutsche Bank
Buy → Hold $24 -24.6% Jul 17, 2026 Downgrade S Stephens
Overweight → Equal-Weight $24 -24.6% Jun 08, 2026 Initiated G Goldman
Neutral $22 -30.9% May 01, 2026 Downgrade B BofA Securities
Buy → Neutral $22 -30.9% Dec 11, 2025 Initiated S Stephens
Overweight $40 +25.7% Oct 02, 2025 Initiated T TD Cowen
Hold $30 -5.7% Apr 30, 2025 Upgrade U UBS
Neutral → Buy $40 +25.7% Jan 23, 2025 Upgrade J Jefferies
Hold → Buy $26 → $35 +10.0% Jan 13, 2025 Upgrade B BofA Securities
Neutral → Buy $26 → $33 +3.7% Dec 05, 2024 Initiated U UBS
Neutral $26 -18.3% Nov 04, 2024 Downgrade G Goldman
Buy → Neutral $27 -15.2% Oct 31, 2024 Downgrade J Jefferies
Buy → Hold $38 → $26 -18.3% Oct 30, 2024 Downgrade B BofA Securities
Buy → Neutral $43 → $29 -8.9% Jul 16, 2024 Initiated J JMP Securities
Mkt Outperform $36 +13.1% Feb 27, 2023 Resumed J Jefferies
Buy $38 +19.4% Jul 19, 2021 Upgrade G Goldman
Neutral → Buy $20 → $25 -21.5% Jan 22, 2021 Initiated D Deutsche Bank
Buy $22 -30.9% Jan 11, 2021 Initiated J JP Morgan
Overweight $21 -34.0% Dec 15, 2020 Initiated G Goldman
Neutral $18 -43.4% Jun 24, 2020 Initiated B BofA/Merrill
Buy $18 -43.4%
Show Previous Ratings
Oct-27-26 02:29PM
Oct-20-26 12:21PM
Oct-18-26 11:08PM
Oct-15-26 07:57AM
Oct-12-26 08:50PM
10:00AM
Loading…
Oct-07-26 10:00AM
Oct-06-26 10:48AM
09:22AM
08:37AM
08:14AM
08:00AM
07:15AM
07:12AM
Oct-05-26 06:27PM
05:16PM
04:45PM
Loading…
04:45PM
04:44PM
Sep-02-26 04:05PM
Jul-29-26 05:03PM
(GuruFocus.com)
+6.45%
-6.14%
07:03AM
07:00AM
Jul-17-26 09:41AM
Jul-09-26 04:05PM
Jun-04-26 07:00AM
Jun-01-26 07:00AM
May-18-26 03:01PM
May-07-26 08:15AM
May-04-26 04:05PM
May-02-26 01:56AM
Apr-30-26 07:05AM
04:05PM
Loading…
Apr-08-26 04:05PM
Mar-06-26 02:00PM
Feb-24-26 04:02PM
12:49PM
11:10AM
09:59AM
08:50AM
07:29AM
07:12AM
(Associated Press Finance)
07:00AM
Feb-23-26 06:15PM
Feb-22-26 10:10PM
Feb-10-26 07:55AM
Feb-06-26 09:21AM
Feb-02-26 12:27PM
Jan-30-26 11:56AM
Jan-29-26 04:05PM
Jan-27-26 12:10PM
Jan-21-26 04:05PM
Jan-14-26 01:11PM
(Investor's Business Daily)
07:11AM
Jan-13-26 07:29PM
06:32PM
04:35PM
03:40PM
11:17AM
Jan-12-26 04:35PM
Dec-22-25 09:14AM
Dec-19-25 09:13AM
Dec-12-25 07:00AM
Dec-09-25 11:21AM
Nov-28-25 07:00AM
(Investor's Business Daily)
Nov-26-25 03:00AM
(Investor's Business Daily)
Nov-25-25 10:40PM
Nov-21-25 06:45PM
Nov-06-25 12:39AM
Nov-03-25 04:05PM
Oct-31-25 09:55AM
Oct-30-25 04:32PM
03:35PM
08:52AM
08:15AM
07:14AM
(Associated Press Finance)
07:00AM
Oct-29-25 11:59AM
Oct-28-25 11:03PM
Oct-23-25 10:00AM
Oct-22-25 09:21AM
Oct-21-25 12:10PM
Oct-18-25 01:50AM
Oct-17-25 09:36AM
Oct-16-25 09:40AM
Oct-14-25 11:40AM
Sep-30-25 09:40AM
Sep-25-25 04:05PM
Sep-23-25 03:26PM
Sep-17-25 01:30AM
Aug-25-25 04:05PM
Aug-21-25 04:59AM
Aug-20-25 08:45AM
Aug-14-25 11:33PM
Aug-12-25 01:02AM
12:53AM
Aug-11-25 04:05PM
Aug-07-25 10:16AM
08:00AM
Aug-03-25 03:16PM
Jul-30-25 08:10AM
Show Previous News
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Smyser Collin GC & Corporate Secretary May 19 '26 Option Exercise 0.00 812 0 75,372 May 21 04:08 PM SULLIVAN TIMOTHY P Director May 07 '26 Buy 20.69 24,154 499,671 73,383 May 07 05:04 PM KRAEMER HARRY M JANSEN JR Director May 04 '26 Buy 21.41 36,610 783,773 450,000 May 05 05:32 PM Sethna Meenal Chief Financial Officer May 04 '26 Buy 20.16 16,225 327,075 98,337 May 04 05:42 PM RADEMACHER JOHN CHARLES Chief Executive Officer May 04 '26 Buy 21.18 12,500 264,706 695,152 May 04 05:41 PM Pate R Carter Director Feb 27 '26 Sale 32.05 30,287 970,620 11,623 Mar 03 04:54 PM Bavaro Michael Chief Human Resources Officer Feb 27 '26 Sale 33.00 6,000 198,000 33,249 Mar 03 04:53 PM Michael L Bavaro Officer Feb 27 '26 Proposed Sale 33.00 6,000 198,000 Feb 27 04:09 PM Pate R Carter Director Feb 26 '26 Proposed Sale 31.89 30,287 965,852 Feb 26 04:49 PM RADEMACHER JOHN CHARLES Chief Executive Officer Feb 21 '26 Option Exercise 0.00 11,087 0 831,506 Feb 24 07:16 PM KRAEMER HARRY M JANSEN JR Director Nov 03 '25 Buy 25.98 38,000 987,392 413,390 Nov 04 04:30 PM
Option Care Health, Inc. engages in the provision of home and alternate site infusion services. The firm provides infusion therapy and other ancillary healthcare services through a national network of full-service pharmacies. The company contracts with managed care organizations, third-party payers, hospitals, physicians, and other referral sources to provide pharmaceuticals and complex compounded solutions to patients for intravenous delivery in the patients' homes or other nonhospital settings. Its home infusion services consist of anti-infectives, nutrition support, bleeding disorder therapies, immunoglobulin therapy, and other therapies for chronic and acute conditions. The company was founded in 1996 and is headquartered in Bannockburn, IL.
CEO Mr. John Charles Rademacher
Executive VP & CFO Ms. Meenal Anil Sethna C.P.A.
Chief Operating Officer Mr. Luke Whitworth
General Counsel & Corporate Secretary Mr. Collin G. Smyser
Senior VP Ms. Nicole Maggio